Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of ADAM17 as a regulatory checkpoint of CD16A in NK cells and as a potential target for cancer immunotherapy
Authors
Keywords
-
Journal
JOURNAL OF LEUKOCYTE BIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-02-21
DOI
10.1002/jlb.2mr1218-501r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells
- (2018) Hemant K. Mishra et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A head-to-tail view of L-selectin and its impact on neutrophil behaviour
- (2018) Aleksandar Ivetic CELL AND TISSUE RESEARCH
- Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells
- (2018) Katja Srpan et al. JOURNAL OF CELL BIOLOGY
- Single Degranulations in NK Cells Can Mediate Target Cell Killing
- (2018) Lavesh A. Gwalani et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer
- (2017) M. Felices et al. GYNECOLOGIC ONCOLOGY
- Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17
- (2017) Petra C. Buchanan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation
- (2017) Marcia L. Moss et al. MEDIATORS OF INFLAMMATION
- Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
- (2017) Thomas Kammertoens et al. NATURE
- Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency
- (2017) Joseph Dosch et al. Oncotarget
- Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during Sepsis
- (2017) Hemant K. Mishra et al. Frontiers in Cellular and Infection Microbiology
- Generation of “Off-the-Shelf” Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
- (2017) Jieming Zeng et al. Stem Cell Reports
- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
- (2017) Congcong Zhang et al. Frontiers in Immunology
- The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
- (2017) Sourav Paul et al. Frontiers in Immunology
- ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer
- (2016) Reba Mustafi et al. CLINICAL CANCER RESEARCH
- NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing
- (2016) Hsiang-Ting Hsu et al. JOURNAL OF CELL BIOLOGY
- Molecular basis for the mechanism of action of an anti-TACE antibody
- (2016) Li Peng et al. mAbs
- The role of ADAM17 in tumorigenesis and progression of breast cancer
- (2016) Hongyu Shen et al. TUMOR BIOLOGY
- ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview
- (2016) Soichi Takeda Toxins
- A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
- (2016) Nives Giebeler et al. Toxins
- Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
- (2015) F Caiazza et al. BRITISH JOURNAL OF CANCER
- Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
- (2015) Markus Granzin et al. CYTOTHERAPY
- Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions
- (2015) Simone Battella et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways
- (2015) J. Rios-Doria et al. MOLECULAR CANCER THERAPEUTICS
- Cytokine secretion and NK cell activity in human ADAM17 deficiency
- (2015) Pinchas Tsukerman et al. Oncotarget
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients
- (2015) M Christina Cox et al. OncoImmunology
- Identification of an ADAM17 Cleavage Region in Human CD16 (FcγRIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells
- (2015) Yawu Jing et al. PLoS One
- Cutting Edge: The Metalloproteinase ADAM17/TNF- -Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
- (2014) P. Boutet et al. JOURNAL OF IMMUNOLOGY
- Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy
- (2014) Hang Fai Kwok et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy
- (2013) Q. Zhou et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17
- (2013) Guranda Chitadze et al. INTERNATIONAL JOURNAL OF CANCER
- Activity of ADAM17 (a Disintegrin and Metalloprotease 17) Is Regulated by Its Noncatalytic Domains and Secondary Structure of its Substrates
- (2013) Roma Stawikowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Membrane-Type 6 Matrix Metalloproteinase Regulates the Activation-Induced Downmodulation of CD16 in Human Primary NK Cells
- (2013) G. Peruzzi et al. JOURNAL OF IMMUNOLOGY
- ADAM17-Mediated Shedding of Fc RIIIA on Human NK Cells: Identification of the Cleavage Site and Relationship with Activation
- (2013) L. Lajoie et al. JOURNAL OF IMMUNOLOGY
- Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry
- (2013) A. Horowitz et al. Science Translational Medicine
- Fcγ Receptor IIIa Single-Nucleotide Polymorphisms and Haplotypes Affect Human IgG Binding and Are Associated With Lupus Nephritis in African Americans
- (2013) Chaoling Dong et al. Arthritis & Rheumatology
- Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
- (2013) Ursula J. E. Seidel et al. Frontiers in Immunology
- ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils
- (2012) Yue Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Antibody-Dependent Cell-Mediated Cytotoxicity Overcomes NK Cell Resistance in MLL-Rearranged Leukemia Expressing Inhibitory KIR Ligands but Not Activating Ligands
- (2012) W. K. Chan et al. CLINICAL CANCER RESEARCH
- Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity
- (2012) Jennifer T. Grier et al. JOURNAL OF CLINICAL INVESTIGATION
- ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment
- (2012) C. Long et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo
- (2012) Frances M. Richards et al. PLoS One
- Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism
- (2011) S. Veeramani et al. BLOOD
- l-Selectin – A dynamic regulator of leukocyte migration
- (2011) Stefanie Wedepohl et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Different Signaling Pathways Stimulate a Disintegrin and Metalloprotease-17 (ADAM17) in Neutrophils during Apoptosis and Activation
- (2011) Yue Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1
- (2011) Ruipeng Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inflammatory Skin and Bowel Disease Linked toADAM17Deletion
- (2011) Diana C. Blaydon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-domain inhibition of TACE ectodomain
- (2011) C. J. Tape et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
- (2010) Athena Chalaris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
- (2009) Y. T. Bryceson et al. BLOOD
- Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection
- (2009) Q. Liu et al. JOURNAL OF VIROLOGY
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search